WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002028378) COMBINATION PARTICLES FOR THE TREATMENT OF ASTHMA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/028378    International Application No.:    PCT/FI2001/000864
Publication Date: 11.04.2002 International Filing Date: 05.10.2001
Chapter 2 Demand Filed:    26.04.2002    
IPC:
A61K 31/57 (2006.01)
Applicants: ORION CORPORATION [FI/FI]; Orionintie 1 FIN-02200 Espoo (FI) (For All Designated States Except US).
WATANABE, Wiwik [ID/FI]; (FI) (For US Only).
KAUPPINEN, Esko [FI/FI]; (FI) (For US Only).
AHONEN, Petri [FI/FI]; (FI) (For US Only).
BROWN, David [US/FI]; (FI) (For US Only).
MUTTONEN, Esa [FI/FI]; (FI) (For US Only)
Inventors: WATANABE, Wiwik; (FI).
KAUPPINEN, Esko; (FI).
AHONEN, Petri; (FI).
BROWN, David; (FI).
MUTTONEN, Esa; (FI)
Agent: ORION CORPORATION; Orion Pharma Industrial Property Rights P.O.Box 65 FIN-02101 Espoo (FI)
Priority Data:
20002216 06.10.2000 FI
Title (EN) COMBINATION PARTICLES FOR THE TREATMENT OF ASTHMA
(FR) PARTICULES ASSOCIEES POUR LE TRAITEMENT DE L'ASTHME
Abstract: front page image
(EN)Inhalation particles incorporating, in an individual particle, a combination of a $g(b)¿2?-agonist and a glucocorticosteroid in a predetermined and constant ratio, a process for the preparation thereof and pharmaceutical compositions comprising the inhalation particles are disclosed. The particles have narrow particle size distribution and are preferably in the form of spherical crystalline particles with a rough surface. The particles are particularly useful in the treatment of asthma and other respiratory disorders.
(FR)L'invention concerne des particules d'inhalation contenant, dans une particule individuelle, une association d'un agoniste $g(b)?2¿ et d'un glucocorticostéroïde en un rapport prédéterminé et constant, un processus de préparation de celles-ci et des compositions pharmaceutiques contenant les particules d'inhalation. Les particules ont une graunulométrie étroite et se présentent de préférence sous la forme de particules cristallines sphériques à surface rugueuse. Les particules sont particulièrement utiles dans le traitement de l'asthme et d'autres troubles respiratoires.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)